Incyte Corp. (INCY) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Incyte’s revenue went from $1.1B in fiscal 2016 to $5.1B in fiscal 2025, growth of about 18.6% a year.
Net income in fiscal 2025 was $1.3B, a net margin of 25.0%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $6.0B and net income $403M.
The diluted share count rose 3% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.1B | $4.2B | $3.7B | $3.4B | $3.0B | $2.7B | $2.2B | $1.9B | $1.5B | $1.1B |
| Gross profit | $5.6B | $4.8B | $3.9B | $3.4B | $3.2B | $2.8B | $2.5B | $2.0B | $1.8B | $1.5B | $1.0B |
| Operating income | $627M | $1.5B | $61M | $621M | $579M | $586M | -$264M | $402M | $129M | -$243M | $145M |
| Net income | $403M | $1.3B | $33M | $598M | $341M | $949M | -$296M | $447M | $109M | -$313M | $104M |
| EPS (diluted) | $1.96 | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 |
| R&D | $3.4B | $2.1B | $2.6B | $1.6B | $1.6B | $1.5B | $2.2B | $1.2B | $1.2B | $1.3B | $582M |
| Revenue growth | — | +21.2% | +14.8% | +8.9% | +13.7% | +12.0% | +23.5% | +14.7% | +22.5% | +38.9% | +46.7% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $745M | $1.4B | $335M | $496M | $970M | $749M | -$125M | $711M | $336M | -$93M | $305M |
| Capital spending | -$65M | — | — | — | -$78M | -$181M | -$187M | -$78M | -$73M | -$111M | -$120M |
| Free cash flow | $680M | — | — | — | $892M | $568M | -$312M | $633M | $263M | -$204M | $184M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $0 | $2.0B | $0 | $0 | — | — | — | — | — | — |
| Stock-based pay | $263M | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $3.1B | $1.7B | $3.7B | $3.2B | $2.3B | $1.8B | $2.1B | $1.4B | $1.2B | $809M |
| Debt | — | $20M | $22M | $20M | $22M | $26M | $27M | $21M | $19.1B | $27M | $750M |
| Equity | — | $5.2B | $3.4B | $5.2B | $4.4B | $3.8B | $2.6B | $2.6B | $1.9B | $1.6B | $419M |
| Total assets | — | $7.0B | $5.4B | $6.8B | $5.8B | $4.9B | $3.6B | $3.4B | $2.6B | $2.3B | $1.6B |
| Shares (diluted) | 203M | 201M | 211M | 226M | 224M | 222M | 218M | 218M | 216M | 205M | 194M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 92.7% | 92.8% | 92.6% | 93.1% | 93.9% | 94.9% | 95.1% | 94.7% | 95.0% | 94.8% | 94.7% |
| Operating margin | 10.4% | 29.5% | 1.5% | 16.8% | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.8% | 13.1% |
| Net margin | 6.7% | 25.0% | 0.8% | 16.2% | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | -20.4% | 9.4% |
| FCF margin | 11.3% | — | — | — | 26.3% | 19.0% | -11.7% | 29.3% | 14.0% | -13.3% | 16.7% |
| ROIC | — | 22.6% | 1.4% | 8.5% | 8.5% | 12.2% | -7.9% | 14.1% | 0.6% | -11.6% | 12.0% |
| ROE | — | 24.9% | 0.9% | 11.5% | 7.8% | 25.2% | -11.3% | 17.2% | 5.7% | -19.2% | 24.9% |
Frequently asked questions
What is Incyte’s annual revenue?
$5.1B in fiscal 2025 and $6.0B over the twelve months to September 30, 2026.
How much profit does Incyte make?
Net income was $1.3B in fiscal 2025 (net margin 25.0%).
Is Incyte’s revenue growing?
Yes: revenue rose 21.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.